arrow
D

David Arnold

university of glasgow
H指数:39
被引数:7,622

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The DEXACELL trial-a protocol for a pragmatic, multicentre, double-blind, placebo-controlled, randomised, parallel group, phase 3 superiority trial to assess the effectiveness and cost-effectiveness of DEXAmethasone as an adjunctive therapy for the management of CELLulitis in adults presenting to urgent secondary care in the UK
2025-10-290
OA
Vaccine effectiveness of a bivalent respiratory syncytial virus (RSV) pre-F vaccine against RSV-associated hospital admission among adults aged 75–79 years in England: a multicentre, test-negative, case–control study

英格兰75~79岁成人中,针对RSV相关住院的bivalent respiratory syncytial virus (RSV) pre-F疫苗的有效性:一项多中心、测试阴性、病例对照研究

2025-10-270
OAAI
PET-CT-guided versus CT-guided biopsy in suspected malignant pleural thickening: a randomised trial
2023-12-146
OAAI
Fibroblast growth factor receptor (FGFR) co-alteration (co-alt) landscape and its impact on erdafitinib (erda) response in the phase II open-label, single-arm RAGNAR trial

成纤维细胞生长因子受体 (FGFR) 共改变 (co-alt) 景观及其对二期开放标签单臂RAGNAR试验中erdafitinib (erda) 反应的影响

2023-10-010
OA
Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A mendelian randomisation study

IL6R阻断治疗脓毒症和脓毒症相关死亡的治疗潜力: 孟德尔随机研究

2023-01-3055
OAAI
Bleeding Risk With Combination Intrapleural Fibrinolytic and Enzyme Therapy in Pleural Infection An International, Multicenter, Retrospective Cohort Study
CHEST
IF8.6
2022-12-0121
OAAI
Development and evaluation of low-volume tests to detect and characterize antibodies to SARS-CoV-2
2022-11-092
OAAI